Net profit of Caplin Point Laboratories rose 13.87% to Rs 130.80 crore in the quarter ended September 2024 as against Rs 114.87 crore during the previous quarter ended September 2023. Sales rose 17.81% to Rs 483.10 crore in the quarter ended September 2024 as against Rs 410.06 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales483.10410.06 18 OPM %34.0833.51 - PBDT185.22157.76 17 PBT168.46146.00 15 NP130.80114.87 14 Powered by Capital Market - Live News

Caplin Point Laboratories will hold a meeting of the Board of Directors of the Company on 7 November 2024Powered by Capital Market - Live News

Caplin Point Laboratories announced that the 33th Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live News

Caplin Point Laboratories announced that the Board of Directors of the Company at its meeting held on 7 August 2024, inter alia, have recommended the final dividend of Rs 2.5 per equity Share (i.e. 125%) , subject to the approval of the shareholders.Powered by Capital Market - Live News

Net profit of Caplin Point Laboratories rose 19.86% to Rs 123.97 crore in the quarter ended June 2024 as against Rs 103.43 crore during the previous quarter ended June 2023. Sales rose 16.10% to Rs 458.96 crore in the quarter ended June 2024 as against Rs 395.32 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales458.96395.32 16 OPM %33.0832.01 - PBDT170.34138.37 23 PBT154.38126.99 22 NP123.97103.43 20 Powered by Capital Market - Live News